Clinical Trials Browser

Phase 4 × OTHER × Afatinib × Clear all

NCT04814056 2021-04-01

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

Phase 4 Unknown

NRG1-fused Non-small Cell Lung Cancer